{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:37:46Z","timestamp":1791999466223,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Silico Pharmacol."],"DOI":"10.1007\/s40203-025-00398-2","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:02:33Z","timestamp":1756720953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the neuroprotective potential of Mucuna pruriens and Boswellia serrata in Huntington\u2019s disease: an integrative bioinformatics approach"],"prefix":"10.1007","volume":"13","author":[{"given":"Pallavi V.","family":"Bhosle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailesh J.","family":"Wadher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"5","key":"398_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/ph17050617","volume":"17","author":"R Arif","year":"2024","unstructured":"Arif R, Bukhari SA, Mustafa G et al (2024) Network pharmacology and experimental validation to explore the potential mechanism of Nigella sativa for the treatment of breast cancer. Pharmaceuticals 17(5):617. https:\/\/doi.org\/10.3390\/ph17050617","journal-title":"Pharmaceuticals"},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"590477","DOI":"10.3389\/fphar.2021.590477","volume":"28","author":"J Chen","year":"2021","unstructured":"Chen J, Li LF, Hu XR, Wei F, Ma S (2021) Network pharmacology-based strategy for elucidating the molecular basis for the pharmacologic effects of licorice (Glycyrrhiza spp.). Front Pharmacol 28:590477. https:\/\/doi.org\/10.3389\/fphar.2021.590477","journal-title":"Front Pharmacol"},{"issue":"23","key":"398_CR3","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1016\/j.csbj.2024.10.009","volume":"10","author":"L Daou","year":"2024","unstructured":"Daou L, Hanna EM (2024) Predicting protein complexes in protein interaction networks using Mapper and graph convolution networks. Comput Struct Biotechnol J 10(23):3595\u20133609. https:\/\/doi.org\/10.1016\/j.csbj.2024.10.009","journal-title":"Comput Struct Biotechnol J"},{"issue":"21","key":"398_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.csbj.2022.12.022","volume":"16","author":"G Galindez","year":"2022","unstructured":"Galindez G, Sadegh S, Baumbach J, Kacprowski T, List M (2022) Network-based approaches for modeling disease regulation and progression. Comput Struct Biotechnol J 16(21):780\u2013795. https:\/\/doi.org\/10.1016\/j.csbj.2022.12.022","journal-title":"Comput Struct Biotechnol J"},{"key":"398_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.987174","volume":"14","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Ebrahimzadeh K, Noroozi R (2022) The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington\u2019s disease. Front Aging Neurosci 14:987174. https:\/\/doi.org\/10.3389\/fnagi.2022.987174","journal-title":"Front Aging Neurosci"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","volume":"1049","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJJP (2018) Clinical features of Huntington\u2019s disease. Polyglutamine Disord 1049:1\u201328. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_1","journal-title":"Polyglutamine Disord"},{"issue":"6","key":"398_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordeli\u00e8res FP, Connors NC, Datta SR, Finkbeiner S et al (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2(6):831\u2013837. https:\/\/doi.org\/10.1016\/S1534-5807(02)00188-0","journal-title":"Dev Cell"},{"key":"398_CR8","doi-asserted-by":"publisher","first-page":"1900325","DOI":"10.1002\/pmic.201900325","volume":"20","author":"HY Hwang","year":"2020","unstructured":"Hwang HY, Kim TY, Sz\u00e1sz MA et al (2020) Profiling the protein targets of unmodified bio-active molecules with drug affinity respon sive target stability and liquid chromatography\/tandem mass spectrometry. Proteomics 20:1900325. https:\/\/doi.org\/10.1002\/pmic.201900325","journal-title":"Proteomics"},{"key":"398_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1080\/1475","volume":"36","author":"YJ Hwang","year":"2021","unstructured":"Hwang YJ, Hyeon S et al (2021) Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington\u2019s disease mouse model. J Enzyme Inhibit Med Chem 36:856\u2013868. https:\/\/doi.org\/10.1080\/1475","journal-title":"J Enzyme Inhibit Med Chem"},{"issue":"4","key":"398_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1471-4159.2012.07925.x","volume":"123","author":"J Jin","year":"2012","unstructured":"Jin J, Cheng Y, Zhang Y et al (2012) Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory net work that is perturbed by mutant huntingtin. J Neurochem 123(4):477\u2013490. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07925.x","journal-title":"J Neurochem"},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","volume":"133","author":"E Junn","year":"2012","unstructured":"Junn E, Mouradian MM (2012) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133:142\u2013150. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.10.002","journal-title":"Pharmacol Ther"},{"key":"398_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02176-2","author":"S Karima","year":"2024","unstructured":"Karima S, Khatami SH et al (2024) Acetyl 11-keto beta-boswellic acid improves neurological functions in a mouse model of multiple sclerosis. Inflammation. https:\/\/doi.org\/10.1007\/s10753-024-02176-2","journal-title":"Inflammation"},{"key":"398_CR31","doi-asserted-by":"publisher","unstructured":"Khan H, Ullah H, Tundis R, Belwal T, Devkota HP, Daglia M, Cetin Z, Saygili EI, da Gra\u00e7a Campos M, Capanoglu E, Du M, Dar P, Xiao J (2020) Dietary flavonoids in the management of huntington\u2019s disease: mechanism and clinical perspective. EFood 1(1):38\u201352. https:\/\/doi.org\/10.2991\/efood.k.200203.001","DOI":"10.2991\/efood.k.200203.001"},{"key":"398_CR13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/neurolint16060112","volume":"16","author":"A Mata-Bermudez","year":"2024","unstructured":"Mata-Bermudez A, Diaz-Ruiz A, Silva-Garc\u00eda LR et al (2024) Mucuna pruriens, a possible treatment for depressive disorders. Neurol Int 16:1509\u20131527. https:\/\/doi.org\/10.3390\/neurolint16060112","journal-title":"Neurol Int"},{"issue":"1","key":"398_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"key":"398_CR15","doi-asserted-by":"publisher","first-page":"117793222312100","DOI":"10.1177\/11779322231210098","volume":"17","author":"TM Meem","year":"2023","unstructured":"Meem TM, Khan U, Mredul MBR, Awal MA, Rahman MH, Khan MS (2023) A comprehensive bioinformatics approach to identify mo lecular signatures and key pathways for the Huntington disease. BioinformatBiolInsights 17:11779322231210098. https:\/\/doi.org\/10.1177\/11779322231210098","journal-title":"BioinformatBiolInsights"},{"key":"398_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/jhg.2016.91","volume":"62","author":"M Molasy","year":"2017","unstructured":"Molasy M, Walczak A, Szaflik J et al (2017) Micrornas in glaucoma and neurodegenerative diseases. J Hum Genet 62:105\u2013112. https:\/\/doi.org\/10.1038\/jhg.2016.91","journal-title":"J Hum Genet"},{"key":"398_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-014-0060-2","volume":"7","author":"A Neueder","year":"2014","unstructured":"Neueder A, Bates GP (2014) A common gene expression signature in Huntington\u2019s disease patient brain regions. BMC Med Genet 7:60. https:\/\/doi.org\/10.1186\/s12920-014-0060-2","journal-title":"BMC Med Genet"},{"issue":"Apr","key":"398_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100046","volume":"47","author":"YM Oh","year":"2024","unstructured":"Oh YM, Lee SW (2024) Patient-derived neuron model: capturing age-dependent adult-onset degenerative pathology in Huntington\u2019s disease. Mol Cells 47(Apr):100046. https:\/\/doi.org\/10.1016\/j.mocell.2024.100046","journal-title":"Mol Cells"},{"key":"398_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2019.100193","volume":"16","author":"MR Rahman","year":"2019","unstructured":"Rahman MR, Islam T, Huq F et al (2019) Identification of molecular signatures and pathways common to blood cells and brain tissue of amyotrophic lateral sclerosis patients. Inf Med Unlocked 16:100193. https:\/\/doi.org\/10.1016\/j.imu.2019.100193","journal-title":"Inf Med Unlocked"},{"key":"398_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00421","volume":"9","author":"SN Rai","year":"2017","unstructured":"Rai SN, Birla H, Singh SS et al (2017) Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u03baB\/pAKT signaling pathways. Front Aging Neurosci 9:421. https:\/\/doi.org\/10.3389\/fnagi.2017.00421","journal-title":"Front Aging Neurosci"},{"key":"398_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.22038\/IJBMS.2020.35288.8419","volume":"23","author":"A Rajabian","year":"2020","unstructured":"Rajabian A, Sadeghnia H, Fanoudi S, Hosseini A (2020) Genus Boswellia as a new candidate for neurodegenerative disorders. Iran J Basic Med Sci 23:277\u2013286. https:\/\/doi.org\/10.22038\/IJBMS.2020.35288.8419","journal-title":"Iran J Basic Med Sci"},{"issue":"10","key":"398_CR22","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.33472\/AFJBS.6.10.2024.4444-4465","volume":"6","author":"SM Shaheedha","year":"2024","unstructured":"Shaheedha SM, Dogiparthi LK, Prakash R et al (2024) Antioxidant and anti-inflammatory properties of Boswellia serrata extract: implications for neuroprotection. Afr J Bio Sci 6(10):4444\u20134465. https:\/\/doi.org\/10.33472\/AFJBS.6.10.2024.4444-4465","journal-title":"Afr J Bio Sci"},{"key":"398_CR30","doi-asserted-by":"publisher","unstructured":"Sharma R, Garg N, Verma D, Rathi P, Sharma V, Kuca K, Prajapati PK (2021) Indian medicinal plants as drug leads in neurodegenerative disorders. In: Nutraceuticals in brain health and beyond. Academic Press, pp 31\u201345. https:\/\/doi.org\/10.1016\/B978-0-12-820593-8.00004-5","DOI":"10.1016\/B978-0-12-820593-8.00004-5"},{"key":"398_CR23","doi-asserted-by":"publisher","first-page":"100921","DOI":"10.1016\/j.jafr.2024.100921","volume":"15","author":"D Sowdhanya","year":"2024","unstructured":"Sowdhanya D, Singh S et al (2024) Nutritional significance of velvet bean (Mucuna pruriens) and opportunities for its processing into value-added products. J Agric Food Res 15:100921. https:\/\/doi.org\/10.1016\/j.jafr.2024.100921","journal-title":"J Agric Food Res"},{"key":"398_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2015.10.060","volume":"625","author":"EA Thomas","year":"2016","unstructured":"Thomas EA (2016) DNA methylation in Huntington\u2019s disease: implications for transgenerational effects. Neurosci Lett 625:34\u201339. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.060","journal-title":"Neurosci Lett"},{"key":"398_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/814068","author":"R Venkatesan","year":"2015","unstructured":"Venkatesan R, Ji E, Kim SY (2015) Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/814068","journal-title":"Biomed Res Int"},{"issue":"4","key":"398_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.31083\/j.jin.2020.04.203","volume":"19","author":"ZM Wang","year":"2020","unstructured":"Wang ZM, Dong XY, Cong SY (2020) Bioinformatic analysis of a microRNA regulatory network in Huntington\u2019s disease. J Integr Neurosci 19(4):641\u2013650. https:\/\/doi.org\/10.31083\/j.jin.2020.04.203","journal-title":"J Integr Neurosci"},{"key":"398_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02549-9","author":"C Xiang","year":"2020","unstructured":"Xiang C, Cong S, Liang B, Cong S (2020) Bioinformatic gene analysis for potential therapeutic targets of Huntington\u2019s disease in pre-symptomatic and symptomatic stage. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-020-02549-9","journal-title":"J Transl Med"},{"issue":"8","key":"398_CR28","doi-asserted-by":"publisher","first-page":"9234","DOI":"10.3390\/cimb46080545","volume":"46","author":"SB Zaigham","year":"2024","unstructured":"Zaigham SB, Paeng DG (2024) Effects of Mucuna pruriens(L.) DC. and levodopa in improving Parkinson\u2019s disease in rotenone-intoxicated mice. Curr Issues Mol Biol 46(8):9234\u20139244. https:\/\/doi.org\/10.3390\/cimb46080545","journal-title":"Curr Issues Mol Biol"},{"issue":"5\u20136","key":"398_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81(5\u20136):294\u2013330. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.01.003","journal-title":"Prog Neurobiol"}],"container-title":["In Silico Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40203-025-00398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40203-025-00398-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40203-025-00398-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:02:37Z","timestamp":1756720957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40203-025-00398-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1007\/s40203-025-00398-2","relation":{},"ISSN":["2193-9616"],"issn-type":[{"value":"2193-9616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Institutional Animal Ethics Committee (IAEC) and adhered to CPCSEA guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"For studies involving plants, this study complies with all relevant local, national, and international guidelines and legislation. All necessary ermissions and licenses for plant collection and usage have been obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with guidelines"}}],"article-number":"123"}}